ATE91124T1 - N-(((2,6-disubstituierte)phenyl>-n'-diarylalkyl harnstoffe als antihyperlipidemische und antiatherosclerotische mittel. - Google Patents

N-(((2,6-disubstituierte)phenyl>-n'-diarylalkyl harnstoffe als antihyperlipidemische und antiatherosclerotische mittel.

Info

Publication number
ATE91124T1
ATE91124T1 AT89105545T AT89105545T ATE91124T1 AT E91124 T1 ATE91124 T1 AT E91124T1 AT 89105545 T AT89105545 T AT 89105545T AT 89105545 T AT89105545 T AT 89105545T AT E91124 T1 ATE91124 T1 AT E91124T1
Authority
AT
Austria
Prior art keywords
diarylalkyl
antihyperlipidemic
ureas
disubstituted
phenyl
Prior art date
Application number
AT89105545T
Other languages
English (en)
Inventor
Bharat Kalidas Trivedi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE91124T1 publication Critical patent/ATE91124T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
AT89105545T 1988-03-30 1989-03-29 N-(((2,6-disubstituierte)phenyl>-n'-diarylalkyl harnstoffe als antihyperlipidemische und antiatherosclerotische mittel. ATE91124T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/176,079 US5116848A (en) 1988-03-30 1988-03-30 N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
EP89105545A EP0335374B1 (de) 1988-03-30 1989-03-29 N-[[(2,6-disubstituierte)phenyl]-N'-diarylalkyl] Harnstoffe als antihyperlipidemische und antiatherosclerotische Mittel

Publications (1)

Publication Number Publication Date
ATE91124T1 true ATE91124T1 (de) 1993-07-15

Family

ID=22642887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89105545T ATE91124T1 (de) 1988-03-30 1989-03-29 N-(((2,6-disubstituierte)phenyl>-n'-diarylalkyl harnstoffe als antihyperlipidemische und antiatherosclerotische mittel.

Country Status (6)

Country Link
US (1) US5116848A (de)
EP (1) EP0335374B1 (de)
JP (1) JPH0725728B2 (de)
AT (1) ATE91124T1 (de)
DE (1) DE68907359T2 (de)
ES (1) ES2056992T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030653A (en) * 1988-03-30 1991-07-09 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
US5155127A (en) * 1989-02-09 1992-10-13 Warner-Lambert Company N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
JPH0395153A (ja) * 1989-06-15 1991-04-19 Mitsubishi Kasei Corp ジフェニル尿素誘導体
CA2022346A1 (en) * 1989-08-04 1991-02-05 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
AU6578090A (en) * 1989-11-06 1991-05-09 Warner-Lambert Company Acat inhibitors
IL100915A (en) * 1991-02-19 1996-03-31 Erba Carlo Spa Double-transformed urea and theories, their preparation and pharmaceutical preparations containing them
HUT62558A (en) * 1991-07-01 1993-05-28 Sandoz Ag Process for producing n-phenylthiourea derivaties and pharmaceutical compositions comprising same
FR2679555B1 (fr) * 1991-07-25 1993-11-19 Fabre Medicament Pierre Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
WO1993024458A1 (en) * 1992-05-28 1993-12-09 Pfizer Inc. New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
US5312820A (en) * 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
CA2107196A1 (en) * 1992-09-29 1994-03-30 Mitsubishi Chemical Corporation Carboxamide derivatives
US5576335A (en) * 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
US5461049A (en) * 1994-05-27 1995-10-24 Warner-Lambert Company Amide tetrazole ACAT inhibitors
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
EP0742208A1 (de) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamid-Derivate
ES2239145T3 (es) * 2000-02-02 2005-09-16 Warner-Lambert Company Llc Inhibidor doble de la sintesis de ester de colesterilo y de ester de cera avasimibe para el tratamiento de trastornos de la glandula sebacea.
US20070151306A1 (en) 2005-12-30 2007-07-05 Gilboe Kevin J Modular laundry system with work surface
US9254566B2 (en) 2009-03-13 2016-02-09 Kawasaki Jukogyo Kabushiki Kaisha Robot having end effector and method of operating the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2911393A (en) * 1956-06-15 1959-11-03 Vanderbilt Co R T Chloroprene polymers containing asymmetric di-substituted thiourea accelerators
US3028391A (en) * 1960-03-30 1962-04-03 Searle & Co 1-alkyl-3-(alpha-phenyl-4-pyridylmethyl) ureas and thioureas
GB1461806A (en) * 1974-03-05 1977-01-19 Wyeth John & Brother Ltd Pyridine derivatives
WO1981002156A1 (en) * 1980-01-25 1981-08-06 Reanal Finomvegyszergyar Process for the preparation of n-aryl-n'-(mono-or disubstiuted)-urea derivatives
US4387106A (en) * 1982-01-26 1983-06-07 American Cyanamid Company Method of treating atherosclerosis with di(aralkyl)ureas and di(aralkyl)thioureas
US4473579A (en) * 1982-01-26 1984-09-25 American Cyanamid Company Antiatherosclerotic tetrasubstituted ureas and thioureas
US4397868A (en) * 1982-01-26 1983-08-09 American Cyanamid Company Method of treating atherosclerosis with trisubstituted ureas
IL67417A (en) * 1982-01-26 1989-10-31 American Cyanamid Co Antiatherosclerotic substituted ureas,process for their preparation and pharmaceutical compositions containing them
US4387105A (en) * 1982-01-26 1983-06-07 American Cyanamid Company Methods of treating atherosclerosis with dialkylureas and dialkylthioureas
US4623662A (en) * 1985-05-23 1986-11-18 American Cyanamid Company Antiatherosclerotic ureas and thioureas

Also Published As

Publication number Publication date
EP0335374B1 (de) 1993-06-30
JPH026455A (ja) 1990-01-10
US5116848A (en) 1992-05-26
ES2056992T3 (es) 1994-10-16
DE68907359D1 (de) 1993-08-05
EP0335374A3 (de) 1991-04-10
DE68907359T2 (de) 1993-11-04
EP0335374A2 (de) 1989-10-04
JPH0725728B2 (ja) 1995-03-22

Similar Documents

Publication Publication Date Title
ATE91124T1 (de) N-(((2,6-disubstituierte)phenyl>-n'-diarylalkyl harnstoffe als antihyperlipidemische und antiatherosclerotische mittel.
ATE98223T1 (de) N-(((2,6-disubstituierte)phenyl>n'- arylalkyl> harnstoffe als antihypercholesterolemische und antiatherosclerotische mittel.
ATE90340T1 (de) Antihyperlipidemische und antiatherosclerotische verbindungen und zusammensetzungen.
ATE110713T1 (de) Antihyperlipidemische und antiartherosklerotische harnstoffverbindungen.
BR1100989A (pt) Composto e composição de matéria
DE59000652D1 (de) Verwendung von umsetzungsprodukten von alkenylspirobislactonen und aminen als paraffindispergatoren.
BR9612233A (pt) Elasômero microcelular de poliuretano contendo grupos uréia processo para preparação do mesmo e utilizaç o dos elastômeros microcelulares de poliuretano contendo grupos uréia
DE69315824D1 (de) Anordnung zum überwachen von torsionsschwingungen und betriebsparametern von rotierenden wellen
FI963539A0 (fi) (4,4-difluoribut-3-enyylitio)-substituoituja heterosyklisiä tai karbosyklisiä rengasyhdisteitä, joilla on tuhoeläinmyrkkyvaikutusta
EP0108708A3 (en) N-(cyclopropyl-triazinyl- and -pyrimidinyl)-n'-(arylsulfonyl) ureas with herbicidal activity
ATE94339T1 (de) Herbizide zusammensetzungen von acylierten 1,3dicarbonyl-herbiziden und antidots dafuer.
DE3774858D1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren.
ES2037768T3 (es) Procedimiento para preparar n-(fenil(2,6-disustituido))-ureas y carbamatos inhibidores de acil-coa: colesterol acil-transferasa.
DE59808543D1 (de) Feste mischungen auf der basis von sulfonylharnstoffen und adjuvantien
DE69006048D1 (de) N-(substituierte aryl)-N'-(substituierte alkoxy)-Harnstoffe als antihypercholesterolemische und antiatherosclerotische Mittel.
BR8607060A (pt) 1-aril-4-substituidas-1,4-diidro-5h-tetrazol-5-onas herbicidas e analogos de enxofre dos mesmos
DE3362332D1 (de) N-(aminomethyl-5-oxazolin-2-yl-2)-n'-phenyl ureas
BR8803208A (pt) N-(p-polioxialquil)-n-(alquil)aminas
PT86068A (pt) Processo e instalacao para a concentracao de uma solucao de ureia
ZA90947B (en) Novel n-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and anti-atherosclerotic agents
DE3266645D1 (de) N-(arylthioalkyl)-n'-(aminoalkyl)ureas
ATE91234T1 (de) Verwendung von dimetylheptylphenylbutanoylethanolamin bei der behandlung von hyperuricemie.
DE68920803D1 (de) Stabilisierung und Verringerung der Hintergrund-Fluoreszenz von Hydroxy-cumarin-ester Enzymsubstraten.
ATE69810T1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeure und deren verwendung als collagenaseinhibitoren.
DE3750358D1 (de) Acylierungsprodukte von 9,10-Anthracendicarboxaldehyd-bis-(2-imidazolin-2-yl-hydrazonen).

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee